Hjem › Småcellet lungekræft › Washington › Seattle
Småcellet lungekræft kliniske forsøg i Seattle, WA
10 studier for Småcellet lungekræft søger deltagere på steder i og omkring Seattle (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekruttererFase 1/2
- University of Washington, Fred Hutchinson Cancer Center, Seattle
Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
RekruttererFase 1
- Fred Hutchinson Cancer Research Center, Seattle
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RekruttererFase 1
- University of Washington Fred Hutchinson, Seattle
A Study to Evaluate DJI136, a DLL3-targeted CAR-T Therapy
RekruttererFase 1/2
- Fred Hutchinson Cancer Center, Seattle
A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
RekruttererFase 3
- Swedish Medical Center, Seattle
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
RekruttererFase 1/2
- Avenzo Therapeutics Recruiting Site, Seattle
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
RekruttererFase 1/2
- Fred Hutch Cancer Research, Seattle
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
RekruttererFase 1/2
- Fred Hutch Cancer Center, Seattle
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
RekruttererFase 1/2
- Swedish Cancer Institute, Seattle
Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
RekruttererFase 1
- Swedish Cancer Institute, Seattle
Småcellet lungekræft forsøg i andre byer
- Houston, TX26 studier
- Arlington, VA23 studier
- Boston, MA21 studier
- New York City, NY21 studier
- Nashville, TN20 studier
- Los Angeles, CA20 studier
- Orlando, FL15 studier
- Dallas, TX13 studier
- St. Louis, MO13 studier
- Cleveland, OH13 studier
- Detroit, MI12 studier
- Chicago, IL12 studier
Andre studier i Seattle
- Ikke-småcellet lungecancer53 studier
- Kræft (alle typer)49 studier
- Prostatakræft42 studier
- Akut myeloid leukæmi40 studier
- Brystkræft39 studier
- Metastatisk cancer39 studier
- Colorektal kræft34 studier
- Lungecancer33 studier
- Ægstockræft30 studier
- Multipelt myelom22 studier
- Myelodysplastiske syndromer21 studier
- Akut lymfoblastisk leukæmi21 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.